Authorized purpose: DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.
Clinical role
Fluoroscopic or radiographic acquisition, visualization, guidance, and release-specific image processing.
Images and patients
Fluoroscopy/Angiography · Multi-region
Key limitation
Keep in mind: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.
Which images or clinical context are in scope?Modality: Fluoroscopy/Angiography Anatomy or clinical context: Multi-region Input: X-ray projection data, fluoroscopic sequences, patient positioning, and procedure-specific user inputs.
Who uses it?Intended users: Qualified radiologists, interventional physicians, surgeons, technologists, and other trained fluoroscopy professionals.
What does the software produce?Output: Radiographic or fluoroscopic images, reformats, overlays, measurements, and guidance views for professional review.
What is its most important limitation?Key limitation: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
Clinical takeaway. Clinical role: DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.
Evidence takeaway. Evidence from the reviewed source record: The K180589 FDA decision summary describes DR 800 dynamic fluoroscopy, rapid-sequence and project-radiography workflows, image processing, dose and image-quality evaluation, DICOM functions, and clinical-expert or simulated-use validation. No clinical or animal study and no named AI diagnostic sensitivity or specificity claim is established in the public summary.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
DR 800 with MUSICA Dynamic is a digital radiography and dynamic-fluoroscopy system for routine radiography, positioning, gastrointestinal, urogenital, angiographic, and pediatric examinations across the labeled body regions; it is not a mammography system.
The K180589 FDA decision summary describes DR 800 dynamic fluoroscopy, rapid-sequence and project-radiography workflows, image processing, dose and image-quality evaluation, DICOM functions, and clinical-expert or simulated-use validation. No clinical or animal study and no named AI diagnostic sensitivity or specificity claim is established in the public summary.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The K180589 FDA decision summary describes DR 800 dynamic fluoroscopy, rapid-sequence and project-radiography workflows, image processing, dose and image-quality evaluation, DICOM functions, and clinical-expert or simulated-use validation. No clinical or animal study and no named AI diagnostic sensitivity or specificity claim is established in the public summary.
Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-03
Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K180589 FDA performance package for DR 800 with MUSICA Dynamic
DesignManufacturer detector, radiography, dynamic-fluoroscopy, image-quality, dose, software, DICOM, and usability verification and validation submitted in K180589
PopulationAdult and pediatric radiography, dynamic-fluoroscopy, gastrointestinal, urogenital, angiographic, positioning, and interventional workflows across the labeled body regions
Scopeexact submission
Tested versionDR 800 with MUSICA Dynamic (K180589)
IndependenceSponsor or vendor study
K180589
Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
3 exact-submission FDA recall records in the 2026-09-02 openFDA snapshot identify K180589. Affected model, version, unit, correction, and current manufacturer instructions still require local confirmation. FDA recall Z-2738-2024 is Open, Classified for DR 800. Digital Radiography X-ray System.. FDA reason: Potential for the front lever chain of the DR 800 table to fail. FDA action: Consignees were sent an URGENT FIELD SAFETY NOTICE by email, dated 7/29/24. In the notice, consignees are asked to check the correct tightening of the floor plate fixing bolts if a high and persistent noise is heard from the device during the tilting or elevation movement of the tabletop. If the noise persists, the device must be stopped immediately in a horizontal position at the maximum height. Agfa will coordinate with consignees to schedule an inspection of affected devices and to install hardware intended to reinforce equipment before 10/15/24. The recall notification is to be shared within consignee organizations and forwarded to those devices were transferred to. Consignees are asked to maintain awareness of this notice until devices are corrected. Completed response forms are to be provided via email to cassandra.mcgowan@agfa.com. Consignees with any questions are to call 1-877-777-2432 and reference PRB2001106. FDA recall Z-2202-2020 is Terminated for AGFA Digital Radiography X- Ray system DR 800 with MUSICA Dynamic, Type number: 6010/200 - Product Usage: DR 800: Agfa s DR 800 system is indicated for performing dynamic imaging examinations (fluoroscopy and/or rapid sequence) of the following anatomies/procedures: positioning fluoroscopy procedures, gastro-intestinal examinations, urogenital tract examinations, and angiography. It is intended to replace fluoroscopic images obtained through image intensifier technology. In addition, the system is intended for project radiography of all body parts. The DR 800 is not intended for mammography applications. FDA reason: Under specific conditions (Fluoroscopic exam, ABS=OFF, manual change of parameters) wrong calculation of the dose/minute for fluoroscopy exams can be possible FDA action: Agfa issued Urgent Field Safety Notice via email on 4/21/20 to consignees, letter states reason for recall, health risk and action to take: Acknowledgment, via a feedback form or email, that the information was received and understood was requested from the consignees. FDA recall Z-2056-2019 is Terminated for AGFA Digital Radiography X- Ray system DR 800 with MUSICA Dynamic Product Usage: The Agfa s DR 800 system is indicated for performing dynamic imaging examinations (fluoroscopy and/or rapid sequence) of the following an anatomies/procedures: positioning fluoroscopy procedures, gastro-intestinal examinations, urogenital tract examinations, and angiography. It is intended to replace fluoroscopic images obtained through image intensifier technology. In addition, the system is intended for project radiography of all body parts. The DR 800 is not intended for mammography applications.. FDA reason: The exposed area of fluo exams possibly does not match the active area of the detector within specified limits. FDA action: The firm sent notification letter dated June 27, 2019 to affected customers. The letter identified the affected product problem and actions to be taken. For questions about this matter,contact your local Agfa Imaging organization 1-877-777-2432 and please reference Problem Record. PRB2000198.
FDA source
Exact FDA submission
Checked 2026-09-04
Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: X-ray projection data, fluoroscopic sequences, patient positioning, and procedure-specific user inputs.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: Validate generator, detector, workstation, DICOM transfer, dose reporting, overlays, procedure records, displays, and fallback workflow.
Scope: Product family. Current vendor materials are product-family evidence for K180589; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: Installed fluoroscopy or radiography system with release-specific detector, workstation, software, and procedure-room accessories.
Scope: Product family. Current vendor materials are product-family evidence for K180589; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Radiographic or fluoroscopic images, reformats, overlays, measurements, and guidance views for professional review.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Radiographic or fluoroscopic images, reformats, overlays, measurements, and guidance views for professional review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Installed fluoroscopy or radiography system with release-specific detector, workstation, software, and procedure-room accessories.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K180589; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Current vendor materials are product-family evidence for K180589; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Only qualified radiologists, interventional physicians, surgeons, technologists, and other trained fluoroscopy professionals should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
Product family
Checked 2026-09-03
Current vendor materials are product-family evidence for K180589; confirm the exact cleared version, enabled options, deployment, and local compatibility.
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
exact submission · checked 2026-09-03
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-03
No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Operator selection, patient positioning, contrast, radiation dose, anatomy, device tracking, and procedure-specific conditions affect applicability; the treating physician remains responsible for decisions.
product family · checked 2026-09-03
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
26Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 3 FDA recall candidates were manually reviewed: 3 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 3 postmarket candidate records; 3 have been reviewed (3 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not verified - checked 2026-09-03 - Exact FDA submission
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: LUMINOS Q.namix T and LUMINOS Q.namix R are multifunctional radiography and fluoroscopy systems for routine radiography and fluoroscopic examinations including gastrointestinal, urogenital, arthrographic, angiographic, and pediatric workflows; they are not mammography systems.
Authorized purpose: 3DXR reconstructs cone-beam CT from interventional X-ray acquisitions and uses CleaRecon DL to reduce streak artifacts for display in the advanced workstation workflow.
Authorized purpose: EndoNaut fuses planning images with live fluoroscopy and provides computerized navigation support for fluoroscopy-guided aneurysm repair, embolization, and peripheral-artery procedures involving the chest, abdomen, pelvis, neck, or lower limbs.
EndoNaut overlays preoperative three-dimensional vascular anatomy on live fluoroscopy and supports semi-automatic registration and motion detection for selected aneurysm, angioplasty, stenting, and embolization procedures.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.